Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Loman · SciRah

Researcher profile · Semantic Scholar

N. Loman

Share profile

N. Loman — researcher profile on SciRah

h-index: 54
Works: 180
Citations: 18K

Most-cited papers

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Miguel Martín, F. Holmes, B. Ejlertsen, S. Delaloge +496 more
2017The Lancet Oncology512 citations
Semantic Scholar
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
A. Palazón, P. Tyrakis, David Macías, Pedro Veliça +12 more
2017Cancer Cell447 citations Open access
Semantic Scholar
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
C. Geyer, J. Garber, R. Gelber, G. Yothers +72 more
2022Annals of Oncology431 citations Open access
Semantic Scholar
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
S. Domchek, C. Aghajanian, R. Shapira-Frommer, R. Schmutzler +12 more
2015Gynecologic Oncology283 citations Open access
Semantic Scholar
Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study
J. Staaf, D. Głodzik, A. Bosch, J. Vallon-Christersson +17 more
2019Nature Medicine256 citations Open access
Semantic Scholar
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
L. Saal, J. Vallon-Christersson, Jari Häkkinen, C. Hegardt +15 more
2015Genome Medicine203 citations Open access
Semantic Scholar
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
C. Brueffer, J. Vallon-Christersson, D. Grabau, A. Ehinger +12 more
2018JCO Precision Oncology187 citations Open access
Semantic Scholar
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
T. Rebbeck, N. Mitra, F. Wan, O. Sinilnikova +252 more
2015Journal of the American Medical Association (JAMA)147 citations Open access
Semantic Scholar
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
C. Winter, M. Nilsson, E. Olsson, A. George +16 more
2016Annals of Oncology145 citations Open access
Semantic Scholar
Clinical and molecular complexity of breast cancer metastases.
S. Kimbung, N. Loman, I. Hedenfalk
2015Seminars in Cancer Biology143 citations Open access
Semantic Scholar
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
A. Osorio, R. Milne, Karoline B. Kuchenbaecker, Tereza Vaclová +193 more
2014PLoS Genetics123 citations Open access
Semantic Scholar
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
T. Bachelot, E. Ciruelos, A. Schneeweiss, F. Puglisi +288 more
2019Annals of Oncology108 citations Open access
Semantic Scholar
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
A. Larsson, S. Jansson, P. Bendahl, Charlotte Levin Tykjaer Jörgensen +5 more
2018Breast Cancer Research107 citations Open access
Semantic Scholar
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
D. Głodzik, A. Bosch, J. Hartman, M. Aine +19 more
2020Nature Communications98 citations Open access
Semantic Scholar
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
J. Staaf, Jari Häkkinen, C. Hegardt, L. Saal +21 more
2021npj Breast Cancer92 citations Open access
Semantic Scholar
Refinement of breast cancer molecular classification by miRNA expression profiles
R. Søkilde, Helena Persson, A. Ehinger, A. Pirona +10 more
2019BMC Genomics90 citations Open access
Semantic Scholar
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
T. Rebbeck, T. Friebel, N. Mitra, F. Wan +99 more
2016Breast Cancer Research70 citations Open access
Semantic Scholar
The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
C. Brueffer, S. Gladchuk, C. Winter, J. Vallon-Christersson +11 more
2020bioRxiv67 citations Open access
Semantic Scholar
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer
M. Nilsson, L. Hartman, U. Kristoffersson, O. Johannsson +5 more
2014Breast Cancer Research and Treatment60 citations Open access
Semantic Scholar
Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative
L. Rydén, N. Loman, C. Larsson, C. Hegardt +6 more
2018British Journal of Surgery59 citations Open access
Semantic Scholar
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
J. Vallon-Christersson, Jari Häkkinen, C. Hegardt, L. Saal +11 more
2019Scientific Reports48 citations Open access
Semantic Scholar
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer
S. Kimbung, Ida Johansson, A. Danielsson, S. Veerla +14 more
2015Clinical Cancer Research47 citations Open access
Semantic Scholar
Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
S. Kimbung, Ida Markholm, J. Bjöhle, T. Lekberg +12 more
2017International Journal of Cancer46 citations Open access
Semantic Scholar
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
I. Blanco, Karoline B. Kuchenbaecker, D. Cuadras, Xian-Shu Wang +190 more
2015PLoS ONE42 citations Open access
Semantic Scholar
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
S. Loibl, Chiun-Sheng Huang, M. Mano, E. Mamounas +15 more
2022npj Breast Cancer41 citations Open access
Semantic Scholar
Immune gene expression and response to chemotherapy in advanced breast cancer
T. Foukakis, J. Lövrot, A. Matikas, I. Zerdes +13 more
2018British Journal of Cancer40 citations Open access
Semantic Scholar
Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort
L. Dihge, J. Vallon-Christersson, C. Hegardt, L. Saal +9 more
2019Clinical Cancer Research38 citations Open access
Semantic Scholar
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
A. Matikas, J. Lövrot, A. Ramberg, M. Eriksson +8 more
2018Oncoimmunology38 citations Open access
Semantic Scholar
VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer
A. Tutt, J. Garber, R. Gelber, K. Phillips +16 more
2022Annals of Oncology37 citations Open access
Semantic Scholar
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations.
C. Singer, J. Balmaña, N. Bürki, S. Delaloge +15 more
2019European Journal of Cancer37 citations Open access
Semantic Scholar
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
C. Larsson, A. Ehinger, S. Winslow, K. Leandersson +11 more
2020npj Breast Cancer34 citations Open access
Semantic Scholar
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
S. Blein, C. Bardel, Vincent Danjean, L. McGuffog +202 more
2015Breast Cancer Research33 citations Open access
Semantic Scholar
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
Meliha Mehmeti-Ajradini, C. Bergenfelz, A. Larsson, Robert Carlsson +17 more
2020Life Science Alliance32 citations Open access
Semantic Scholar
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.
N. Tobin, J. Harrell, J. Lövrot, S. E. Brage +12 more
201531 citations Open access
Semantic Scholar
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status
M. Nilsson, L. Hartman, I. Idvall, U. Kristoffersson +2 more
2014Breast Cancer Research and Treatment31 citations Open access
Semantic Scholar
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
Malin Dahlgren, A. George, C. Brueffer, S. Gladchuk +12 more
2021JNCI Cancer Spectrum29 citations Open access
Semantic Scholar
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
O. Borgå, R. Henriksson, H. Bjermo, E. Lilienberg +2 more
2019Advances in Therapy28 citations Open access
Semantic Scholar
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
Kang Wang, I. Zerdes, Henrik J. Johansson, D. Sarhan +13 more
2024Nature Communications24 citations Open access
Semantic Scholar
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
C. Lundgren, P. Bendahl, Å. Borg, A. Ehinger +14 more
2019Breast Cancer Research and Treatment23 citations Open access
Semantic Scholar
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study
M. Nilsson, Erik D. Nilsson, Å. Borg, Y. Brandberg +2 more
2018Breast Cancer Research and Treatment22 citations Open access
Semantic Scholar
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
M. Nilsson, C. Winter, U. Kristoffersson, Martin Rehn +3 more
2017Familial Cancer22 citations Open access
Semantic Scholar
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3
Y. Hamdi, P. Soucy, Karoline Kuchenbaeker, T. Pastinen +164 more
2016Breast Cancer Research and Treatment22 citations Open access
Semantic Scholar
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
D. Förnvik, K. Aaltonen, Yi-Lun Chen, A. George +5 more
2019Breast Cancer Research and Treatment21 citations Open access
Semantic Scholar
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients
N. Tobin, Arian Lundberg, L. Lindström, J. Harrell +11 more
2017Clinical Cancer Research21 citations Open access
Semantic Scholar
96O Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis from KATHERINE
S. Loibl, C.-S. Huang, M. Mano, T. Mamounas +15 more
202020 citations Open access
Semantic Scholar
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
M. Nilsson, T. Törngren, K. Henriksson, U. Kristoffersson +4 more
2017Breast Cancer Research and Treatment20 citations Open access
Semantic Scholar
Clinical Management of Prostate Cancer in Men with BRCA Mutations.
O. Bratt, N. Loman
2015European Urology19 citations Open access
Semantic Scholar
Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
E. Ólafsdóttir, Å. Borg, M. Jensen, A. Gerdes +16 more
2020British Journal of Cancer18 citations Open access
Semantic Scholar
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
A. Matikas, K. Wang, E. Lagoudaki, B. Acs +17 more
2021ESMO Open14 citations Open access
Semantic Scholar
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
H. Saghir, S. Veerla, M. Malmberg, L. Rydén +10 more
2022Cancers13 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Saal×16
Invite
L. Saal — researcher profile on SciRah
C. Larsson×16
Invite
C. Larsson — researcher profile on SciRah
M. Malmberg×16
Invite
M. Malmberg — researcher profile on SciRah
C. Hegardt×15
Invite
C. Hegardt — researcher profile on SciRah

×15

Invite

L. Rydén — researcher profile on SciRah

J. Vallon-Christersson×14

Invite

J. Vallon-Christersson — researcher profile on SciRah

Invite

A. Ehinger — researcher profile on SciRah

Invite

Å. Borg — researcher profile on SciRah

T. Hatschek×11

Invite

T. Hatschek — researcher profile on SciRah

Jari Häkkinen×11

Invite

Jari Häkkinen — researcher profile on SciRah

I. Hedenfalk×8

Invite

I. Hedenfalk — researcher profile on SciRah

Invite

S. Domchek — researcher profile on SciRah